| Lexington Med Ctr Batesburg Leesville | |
|
338 E Columbia Ave Batesburg-leesville SC 29070 | |
| (803) 604-0066 | |
| (803) 604-9924 |
| Full Name | Lexington Med Ctr Batesburg Leesville |
|---|---|
| Speciality | Clinic/center |
| Location | 338 E Columbia Ave, Batesburg-leesville, South Carolina |
| Authorized Official Name and Position | Melinda P Kruzner (SR. VP & CFO) |
| Authorized Official Contact | 8037912000 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Lexington Med Ctr Batesburg Leesville Po Box 896239 Charlotte NC 28289-6239 Ph: (803) 604-0066 | Lexington Med Ctr Batesburg Leesville 338 E Columbia Ave Batesburg-leesville SC 29070 Ph: (803) 604-0066 |
| NPI Number | 1932127883 |
|---|---|
| Provider Enumeration Date | 07/18/2006 |
| Last Update Date | 08/10/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932127883 | NPI | - | NPPES |
| GP1258 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
News Archive
Ankylosing spondylitis (AS) is a complex chronic inflammatory disease of the spine with involvement of the sacroiliac joints.
Akorn, Inc., a niche specialty pharmaceutical company, today reported financial results for the second quarter of 2011. The Company also separately announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat front-of-eye diseases.
Regenerating sensory hair cells, which produce electrical signals in response to vibrations within the inner ear, could form the basis for treating age- or trauma-related hearing loss. One way to do this could be with gene therapy that drives new sensory hair cells to grow.
A new Japanese study examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
› Verified 4 days ago
Lexington Med Ctr Batesburg Leesville Rhc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 338 E Columbia Avenue, Batesburg-leesville, SC 29070 Phone: 803-604-0066 Fax: 803-604-9924 |